(Q45232916)

11 December 2017

title

A pharmacokinetic interaction study between omeprazole and the H2-receptor antagonist ranitidine (English)

1 reference

11 December 2017

1 reference

Leucuta A

1

1 reference

11 December 2017

Vlase L

series ordinal

2

1 reference

11 December 2017

Farcau D

series ordinal

3

1 reference

11 December 2017

Nanulescu M

series ordinal

4

1 reference

11 December 2017

publication date

1 January 2004

1 reference

Drug Metabolism and Drug Interactions

11 December 2017

published in

1 reference

11 December 2017

volume

20

1 reference

11 December 2017

issue

4

1 reference

11 December 2017

page(s)

273-281

1 reference

The clinical importance of proton pump inhibitor pharmacokinetics

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2004.20.4.273

Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2004.20.4.273

Pharmacokinetics of diclofenac and inhibition of cyclooxygenases 1 and 2: no relationship to the CYP2C9 genetic polymorphism in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2004.20.4.273

Effect of single doses of cimetidine and ranitidine on the steady-state plasma levels of midazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2004.20.4.273

A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2004.20.4.273

Interactions and Non-Interactions with Ranitidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2004.20.4.273

10.1515/DMDI.2004.20.4.273

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference